Company Filing History:

18 out of 78

Zambon S.p.a.

Years Active: 1976-1992

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5145872 - Peptides with pharmaceutical activity (1992-09-08),

2. 5028626 - Peptides with pharmaceutical activity (1991-07-02),

3. 4985428 - Isoxazoles with nootropic activity (1991-01-15),

4. 4960788 - Pyrrolidone-2 compounds and their use for central analgesic activity (1990-10-02),

5. 4952596 - Derivatives of thiazolidine-4-carboxylic acid having pharmacological (1990-08-28),

6. 4918095 - Compositions with antibiotic activity and their use (1990-04-17),

7. 4863908 - Mono(2-ammonium-2-hydroxymethyl-1,3 (1989-09-05),

8. 4840936 - Pharmaceutically useful derivatives of thiazolidine-4-carboxylic acid (1989-06-20),

9. 4812477 - Thioesters for the treatment of ischemia and reperfusion syndromes (1989-03-14),

10. 4806567 - Method for the treatment of ischemia and reperfusion syndromes (1989-02-21),

11. 4766138 - Use of 4-(isoxazolyl)-thiazole-2-oxamic acid derivatives (1988-08-23),

12. 4766137 - 4-(isoxazolyl)-thiazole-2-oxamic acids and derivatives thereof (1988-08-23),

13. 4761399 - Dipeptide compounds having pharmaceutical activity and compositions (1988-08-02),

14. 4727065 - Bis-(2-ammonium-2-hydroxymethyl-1,3-propaned (1988-02-23),

15. 4638003 - 1-(4-alkylthiophenyl)-2-(substituted or unsubstituted (1987-01-20),

Title: Davide Della Bella: Innovator in Pharmaceutical Peptides

Introduction

Davide Della Bella, based in Milan, Italy, is a prominent inventor known for his significant contributions to the pharmaceutical field. With a remarkable portfolio of 22 patents, his work primarily focuses on peptides with pharmaceutical activity, showcasing innovative compounds that have the potential to impact drug development.

Latest Patents

Among his latest patents, Della Bella has developed compounds represented by specific formulas that act as inhibitors of enzymatic systems. These compounds are described in detail, highlighting their processes for preparation and their application as active ingredients in pharmaceutical compositions. The innovative nature of these peptides positions them as useful tools in various therapeutic areas, emphasizing their potential benefits in enhancing medical treatments.

Career Highlights

Throughout his career, Davide Della Bella has worked with esteemed companies, notably Zambon S.p.a. and Zambon Group S.p.a. His tenure at these organizations has allowed him to apply his expertise in peptides and their pharmaceutical applications, contributing to advancements in the industry.

Collaborations

Della Bella has collaborated with notable coworkers, including Dario Chiarino and Angelo Carenzi. Their collective efforts have fostered an environment of innovation and research that furthers the development of pharmaceutical technologies.

Conclusion

In conclusion, Davide Della Bella stands out as a significant contributor to the field of pharmaceuticals through his innovative work on peptide compounds. His extensive patent portfolio exemplifies his commitment to enhancing therapeutic options and underscores the importance of collaboration in advancing medical research.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com